Cargando…
Leukotrienes, a potential target for Covid-19
Autores principales: | Citron, Francesca, Perelli, Luigi, Deem, Angela K., Genovese, Giannicola, Viale, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495247/ https://www.ncbi.nlm.nih.gov/pubmed/32977289 http://dx.doi.org/10.1016/j.plefa.2020.102174 |
Ejemplares similares
-
Cysteinyl Leukotrienes as Potential Pharmacological Targets for Cerebral Diseases
por: Gelosa, Paolo, et al.
Publicado: (2017) -
KRAS-Dependency in Pancreatic Ductal Adenocarcinoma: Mechanisms of Escaping in Resistance to KRAS Inhibitors and Perspectives of Therapy
por: Gurreri, Enrico, et al.
Publicado: (2023) -
The Role of Leukotrienes as Potential Therapeutic Targets in Allergic Disorders
por: Jo-Watanabe, Airi, et al.
Publicado: (2019) -
The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
por: Aigner, Ludwig, et al.
Publicado: (2020) -
Leukotriene Signaling as a Target in α-Synucleinopathies
por: Strempfl, Katharina, et al.
Publicado: (2022)